๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Pulmonary hypertension is an important morbidity factor in patients having ...
Status
Completed
Location
Montreal Heart Institute
Start Date
2009-02
Trial ID
NCT00819377
Treatments Being Tested
Right ventricular (RV) failure occurs in an estimated 5-41% of cases involv...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2012-04-05
Trial ID
NCT01571037
Treatments Being Tested
The aim of this study is to examine and compare the effect of Levosimendan ...
Status
Completed
Location
Onassis Cardiac Surgery Center
Start Date
2021-01-27
Trial ID
NCT04718350
Treatments Being Tested
Our main hypothesis is that inhalation of milrinone can reduce the elevated...
Status
Completed
Location
Konkuk University Medical Center
Start Date
2003-01
Trial ID
NCT01621971
Treatments Being Tested
In cardiac surgery, the presence of pulmonary hypertension (PH) is a progno...
Status
Recruiting
Location
Montreal Heart Institute
Start Date
2025-12-10
Trial ID
NCT05450328
Treatments Being Tested
The investigator compared difference between inhaled and intravenous miliri...
Status
Recruiting
Location
Zagazig University
Start Date
2023-05-20
Trial ID
NCT04484675
Treatments Being Tested
Patients with end stage heart failure have significant symptoms (including ...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2020-06-15
Trial ID
NCT02077010
Treatments Being Tested
The purpose of this study is to investigate the concentration-effect relati...
Status
Completed
Location
Montreal Heart Institute
Start Date
2006-12
Trial ID
NCT01725776
Treatments Being Tested
This prospective open-label randomized study aims to compare the effect of ...
Status
Completed
Location
Menoufia University Hospitals
Start Date
2023-04-01
Trial ID
NCT05838846
Treatments Being Tested